Essity AB
ESSITY B
ISIN SE0009922164 / Valor 36851944
Essity AB
UMushroom community rating:
About company
Essity AB is a global hygiene and health company headquartered in Sweden, known for its comprehensive range of products and solutions across various sectors. The company operates in three main business areas: Professional Hygiene, Health & Medical, and Consumer Goods. In Professional Hygiene, Essity provides sustainable hygiene management solutions, including dispensing systems for tissues, soaps, and sanitizers, as well as wiping and cleaning products tailored for commercial and public environments. The Health & Medical segment focuses on supporting patients, caregivers, and healthcare professionals with products and services in incontinence care, wound care, compression therapy, and orthopedics. In the Consumer Goods sector, Essity offers a wide array of personal and home hygiene products, such as baby care, feminine care, incontinence care, and consumer tissue products, catering to various life stages. Essity's commitment to innovation and sustainability is reflected in its diverse product offerings designed to enhance well-being and quality of life.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (11.11.2025):
Essity AB’s report for quarter 4 2024 and the full-year 2024 shows robust momentum with net sales growth and solid organic performance despite some margin pressures. In Q4 2024, net sales increased by 3.2% to SEK 37,805m with organic growth at 3.9% (volume 1.7% and price/mix 2.2%), while EBITA declined slightly by 1% to SEK 4,585m. Excluding restructuring items (IAC), EBITA improved by 2% to SEK 4,969m, though the corresponding margin experienced a minor decrease. For the full-year 2024, while net sales dipped by 1.1% to SEK 145,546m, the company delivered a significantly higher EBITA of SEK 19,475m – up 17% – and profit for the period at SEK 21,048m, alongside the Board’s proposal for a 6.5% dividend increase to SEK 8.25 per share. The report also noted notable targeted cost savings and an upcoming leadership transition as President and CEO Magnus Groth prepares to leave in 2025.
Net Sales & Organic Growth
In quarter 4 2024, Essity AB reported net sales of SEK 37,805m, an increase of 3.2% compared to the previous year, driven by an organic growth rate of 3.9% (with volume contributing 1.7% and price/mix 2.2%). Excluding restructuring, organic growth was even stronger at 4.9%.
EBITA Performance & Margins
EBITA for quarter 4 2024 decreased slightly by 1% to SEK 4,585m, while EBITA excluding IAC improved by 2% to SEK 4,969m. However, the EBITA margin excl. IAC saw a minor contraction by 0.2 percentage points, reflecting higher costs despite favorable pricing and volume effects.
Full-Year Results & Profitability
For full-year 2024, Essity AB’s net sales were SEK 145,546m (a 1.1% decrease), but they achieved a substantial EBITA increase of 17% to SEK 19,475m and recorded the highest-ever full-year profit of SEK 21,048m in total operations. Organic performance and cost-saving measures contributed significantly to these results.
Dividend Proposal & CEO Transition
The Board of Directors has proposed a dividend increase of 6.5% to SEK 8.25 per share, reflecting strong cash flow generation and a commitment to shareholder returns. Additionally, the report announced that President and CEO Magnus Groth will be leaving the company in 2025, marking a key leadership transition.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
17118 M
Market cap (USD)
1,354,822
Daily traded volume (Shares)
297 / 293.6
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
